Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting

OBJECTIVE: The aim of this study was to assess the cost effectiveness of oral semaglutide versus other oral glucose-lowering drugs for the management of type 2 diabetes (T2D) in Sweden. METHODS: The Swedish Institute for Health Economics Diabetes Cohort Model was used to assess the cost effectivenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Eliasson, Björn, Ericsson, Åsa, Fridhammar, Adam, Nilsson, Andreas, Persson, Sofie, Chubb, Barrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043066/
https://www.ncbi.nlm.nih.gov/pubmed/35064550
http://dx.doi.org/10.1007/s41669-021-00317-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043066/
https://www.ncbi.nlm.nih.gov/pubmed/35064550
http://dx.doi.org/10.1007/s41669-021-00317-z

Ejemplares similares